NPI registry status
Active
2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1356608863 MD
Verify on CMS → Ross Lynds, MD
Retina Specialist (Ophthalmology) Physician in Abilene, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 913 in Retina Specialist (Ophthalmology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
681
Medicare Part D claims · 196 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
58%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · Exceptional
Industry payments
$809.43
31 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Ross Lynds, MD reported a CMS MIPS final score of 100/100 - above the 83.1 national average - and filed 681 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 681
- Part D claims, 2023
- 58%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Ross Lynds, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Ross Lynds, MD sits
This provider among retina specialist (ophthalmology) physician peers
Across the 583 retina specialist (ophthalmology) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Ross Lynds, MD writes more Part D claims than 75% of them and scores higher on MIPS quality than 58% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one retina specialist (ophthalmology) physician peer from a representative sample of 60; the gold marker is Ross Lynds, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Ross Lynds, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ross Lynds, MD?
High performer (top quartile)Primary specialty
Retina Specialist (Ophthalmology) Physician
Medicare Part D claims
681 22% vs specialty avg
MIPS final score
100/100 16.9 pts vs avg
Specialty distribution in Texas
How Retina Specialist (Ophthalmology) Physician compares to other specialties among Texas providers
Medicare quality performance, MIPS
Ross Lynds, MD's 2023 MIPS final score plotted against the Retina Specialist (Ophthalmology) Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Retina Specialist (Ophthalmology) Physician) - 100/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Ross Lynds, MD appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding MD credentials at 5441 HEALTH CENTER DR, Abilene, TX, 79606, with a listed phone of (325) 673-9806. NPI 1356608863 was issued on 04/20/2012.
Medicare Part D records for calendar year 2023 show 681 prescription claims written by this provider, covering 196 Medicare beneficiaries and totaling roughly $49K in drug spend, split 42% brand-name and 58% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.
Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1356608863 |
|---|---|
| Specialty | Retina Specialist (Ophthalmology) Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/20/2012 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
100
Final Score
Avg: 83.1
100
Quality
Reporting: Group practice
Hospital and facility affiliations
Facilities where Ross Lynds, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Ophthalmology Specialists OF Texas PLLC
Willow Park, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ross Lynds, MD. Source: openpaymentsdata.cms.gov.
Total received
$809
Largest payer
Sandoz Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Ross Lynds, MD. To verify Ross Lynds, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Ross Lynds, MD - brand share 42.0%
Retina Specialist (Ophthalmology) Physician average
42% brand-name claims vs 58% generic, on 681 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
681
Total Claims
$49K
Total Drug Cost
196
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 934
- Total Day Supply
- 24,220
- Brand vs Generic
- 42% brand / 58% generic
- Brand Drug Cost
- $34K
- Generic Drug Cost
- $15K
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 1.75
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 17, 65-74: 97, 75-84: 59, 85+: 23
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Ross Lynds, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisolone Acetate
Prednisolone Acetate
149 claims
- Latanoprost
Latanoprost
102 claims
- Brimonidine Tartrate
Brimonidine Tartrate
79 claims
- Ofloxacin
Ofloxacin
62 claims
- Moxifloxacin 51
Moxifloxacin
51 claims
- Dorzolamide-Timolol 42
Dorzolamide-Timolol
42 claims
- Timolol Maleate 42
Timolol Maleate
42 claims
- Ketorolac Trometha… 35
Ketorolac Tromethamine
35 claims
| Drug | Claims |
|---|---|
| Prednisolone Acetate | 149 |
| Latanoprost | 102 |
| Brimonidine Tartrate | 79 |
| Ofloxacin | 62 |
| Moxifloxacin Moxifloxacin Hcl | 51 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 42 |
| Timolol Maleate | 42 |
| Ketorolac Tromethamine | 35 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Retina Specialist (Ophthalmology) Physician in TX →
All providers in Texas →
Compare specialties →
Retina Specialist (Ophthalmology) Physician Overview
How Ross Lynds, MD fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.
913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider
Ross Lynds, MD's 681 claims are above the specialty average of 558.
Nearby Retina Specialist (Ophthalmology) Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Lynds.
Dr. Matthew Adams
MD
Plano, TX
Dr. Hasenin Al-Khersan
MD
Bellaire, TX
Dr. Rolake Alabi
MD PHD
Austin, TX
Dr. Harshivinderjit Bains
MD
Tyler, TX
Dr. Touka Banaee
MD
Galveston, TX
Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Retina Specialist (Ophthalmology) Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Texas
Frequently Asked Questions
What is Ross Lynds, MD's specialty? ▼
Ross Lynds, MD specializes in Retina Specialist (Ophthalmology) Physician and practices in Abilene, Texas. Credentials: MD.
How much does Ross Lynds, MD prescribe under Medicare Part D? ▼
In 2023, Ross Lynds, MD wrote 681 Medicare Part D claims totaling $49K in drug costs for 196 beneficiaries.
What is Ross Lynds, MD's Medicare quality score? ▼
Ross Lynds, MD has a CMS MIPS Final Score of 100/100 (Quality: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Ross Lynds, MD located? ▼
Ross Lynds, MD is located at 5441 HEALTH CENTER DR, Abilene, TX, 79606. Phone: (325) 673-9806.
What is Ross Lynds, MD's NPI number? ▼
Ross Lynds, MD's National Provider Identifier (NPI) is 1356608863, issued on 04/20/2012.
Does Ross Lynds, MD prescribe more brand-name or generic drugs? ▼
Ross Lynds, MD's prescribing is 42% brand-name and 58% generic drugs by claim count, with $34K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US? ▼
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does Ross Lynds, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Ross Lynds, MD's most frequently prescribed drugs include Prednisolone Acetate, Latanoprost, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ross Lynds, MD accept Medicare? ▼
Ross Lynds, MD appears in CMS Medicare data with 681 Part D claims and 196 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ross Lynds, MD's credentials? ▼
Ross Lynds, MD's NPI is 1356608863 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.